Vascular Function in Adults With Down Syndrome
University of Nevada, Las Vegas
24 participants
Apr 9, 2026
OBSERVATIONAL
Conditions
Summary
Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becoming a more common cause of death in adults with Ds as life expectancy increases. Despite these findings, studies examining heart and blood vessel health in adults with Ds have produced mixed results, making it difficult to determine their true risk and whether preventive strategies are needed. This study will investigate the health of blood vessels in adults with Ds and compare the results with those of adults without Ds. Healthy blood vessels are important because they help deliver blood and oxygen throughout the body. Changes in blood vessel function and stiffness can occur with aging and may increase the risk of heart disease, stroke, kidney disease, and memory problems. The study aims to determine whether adults with Ds experience changes in blood vessel health that may place them at increased cardiovascular risk. Specifically, the study will: (1) Examine how well blood vessels function in adults with Ds; (2) Measure the stiffness of arteries in adults with Ds; (3) Compare two methods used to assess blood vessel function to determine whether a simpler exercise-based test provides results similar to a commonly used standard test. The findings may improve understanding of cardiovascular risk in adults with Ds and help guide future strategies to promote healthy aging in this population.
Eligibility
Inclusion Criteria6
- between 18 and 35 years old
- generally healthy
- sedentary (defined as being involved in less than 30 minutes of moderately-intense physical activity per day)
- Additionally, for the participants with Down syndrome:
- diagnosis of Down syndrome trisomy 21
- normal thyroid function or stable thyroid function (and medications) for at least 6 mo.
Exclusion Criteria13
- unresolved congenital heart disease;
- atherosclerotic or other vascular disease (such as blood clot history or clotting disorders);
- asthma or other pulmonary disease;
- hypertension (defined BP >140/90 mmHg); blood pressure below 90/60 mmHg;
- history of pre-syncope or syncope;
- diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication);
- severe obesity (defined as BMI >40);
- heart medications affecting heart rate, blood pressure or arterial function, including blood thinners; anti-inflammatory medication including NSAIDS;
- current smoking;
- currently pregnant or planning to become pregnant during the study period;
- currently breastfeeding;
- unable or unwilling to use an acceptable method of contraception during the study timeframe;
- positive pregnancy test at screening.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07630207